---
title: Improve gait and balance remotely
nct_id: NCT06052280
phase: NA
status: RECRUITING
sponsor: Azienda Sanitaria Locale CN1 Cuneo
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06052280"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06052280"
last_fetched: "2026-05-10T14:04:34.216Z"
source: "Parkinson's Pathways (curated)"
---
# Improve gait and balance remotely

**Goal (in five words):** Improve gait and balance remotely

**Official Title:** Management of Initial Parkinson's Disease: a Prospective, Mono-centric, no Profit Pilot Clinical Trial Comparing Conventional Face-to-face Physiotherapy and Home-based Telerehabilitation

**Trial ID:** [NCT06052280](https://clinicaltrials.gov/study/NCT06052280)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Azienda Sanitaria Locale CN1 Cuneo
- **Target Enrollment:** 40 participants
- **Start Date:** 2023-10-09
- **Completion Date:** 2024-10
- **Conditions:** Parkinson Disease
- **Interventions:** Telerehabilitation exercise program, Home self-exercise program
- **Intervention Types:** OTHER

## Summary For Families

The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

General:

* adults, aged 18 or older;
* medical diagnosis of idiopathic PD according the most recent Movement Disorder Society diagnostic criteria;
* disease stage ≤ 2 on the Hoehn\&Yahr scale;
* Montreal Cognitive Assessment score \>25;
* ability to read, understand and provide a written informed consent, in accordance with good clinical practice and local regulations;
* motivation and possibility to show up for planned controls and to comply with the requested study procedures.

Specific for TrE arm:

* wireless internet access at home;
* adequate room to place telerehabilitation device (about 2 meters in front of device monitor).

Exclusion Criteria:

* \<18 years of age;
* Any atypical, iatrogenic, or secondary Parkinsonism;
* Disease stage \> 2 on the Hoehn\&Yahr scale;
* Any severe orthopaedic, vascular, respiratory, or cardiac problems or any other medical condition that, in the principal investigator's opinion, could limit participation in moderate exercise or the study protocol.
```

## Locations (1)

- Azienda Sanitaria Locale CN1, Cuneo, Italy _(44.3907, 7.5483)_
  - Federica Gallo, Biostatistic — (CONTACT) — 0172699235 — federica.gallo@aslcn1.it
  - Elona Bahimi, Neurologist — (CONTACT) — 0174676121 — elona.brahimi@aslcn1.it

## Central Contacts

- Federica Gallo, Biostatistic — (CONTACT) — +390174676121 — federica.gallo@aslcn1.it

---

*Canonical: https://parkinsonspathways.com/trial/NCT06052280*  
*HTML version: https://parkinsonspathways.com/trial/NCT06052280*  
*Source data: https://clinicaltrials.gov/study/NCT06052280*